Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 2,292.40
+42.40 (1.88%)
Jun 1, 2026, 3:30 PM IST
Gland Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 370,702 | 279,443 | 262,358 | 303,932 | 208,882 | 537,705 | |
Market Cap Growth | 57.78% | 6.51% | -13.68% | 45.50% | -61.15% | 32.63% |
Enterprise Value | 339,209 | 250,447 | 236,321 | 286,055 | 175,977 | 508,469 |
Last Close Price | 2250.00 | 1696.10 | 1577.70 | 1809.55 | 1243.71 | 3209.33 |
PE Ratio | 36.13 | 27.20 | 37.56 | 39.35 | 26.74 | 44.38 |
Forward PE | 30.04 | 26.18 | 27.55 | 29.26 | 17.57 | 35.96 |
PS Ratio | 5.76 | 4.35 | 4.67 | 5.37 | 5.76 | 12.22 |
PB Ratio | 3.58 | 2.70 | 2.87 | 3.48 | 2.63 | 7.51 |
P/TBV Ratio | 3.72 | 2.81 | 2.98 | 3.63 | 2.63 | 7.53 |
P/FCF Ratio | 68.57 | 51.69 | 49.48 | 50.08 | 146.03 | 192.42 |
P/OCF Ratio | 35.94 | 27.09 | 28.68 | 30.49 | 57.39 | 68.00 |
PEG Ratio | 1.20 | 0.90 | 1.60 | 1.58 | 1.59 | 1.44 |
EV/Sales Ratio | 5.27 | 3.90 | 4.21 | 5.05 | 4.86 | 11.55 |
EV/EBITDA Ratio | 20.82 | 15.37 | 19.19 | 22.06 | 17.07 | 33.67 |
EV/EBIT Ratio | 28.13 | 20.77 | 27.10 | 29.45 | 19.90 | 36.32 |
EV/FCF Ratio | 62.74 | 46.33 | 44.57 | 47.14 | 123.03 | 181.96 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.04 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.17 | 0.17 | 0.25 | 0.28 | 0.00 | 0.00 |
Debt / FCF Ratio | 0.53 | 0.53 | 0.59 | 0.61 | 0.03 | 0.02 |
Net Debt / Equity Ratio | -0.30 | -0.30 | -0.29 | -0.18 | -0.47 | -0.45 |
Net Debt / EBITDA Ratio | -1.93 | -1.93 | -2.14 | -1.21 | -3.64 | -2.15 |
Net Debt / FCF Ratio | -5.82 | -5.82 | -4.98 | -2.58 | -26.27 | -11.60 |
Asset Turnover | 0.54 | 0.54 | 0.51 | 0.58 | 0.44 | 0.61 |
Inventory Turnover | 1.41 | 1.41 | 1.44 | 1.40 | 1.16 | 1.79 |
Quick Ratio | 3.31 | 3.31 | 3.01 | 2.61 | 6.58 | 7.80 |
Current Ratio | 4.68 | 4.68 | 4.34 | 4.04 | 9.46 | 10.06 |
Return on Equity (ROE) | 10.53% | 10.53% | 7.82% | 9.26% | 10.33% | 18.55% |
Return on Assets (ROA) | 6.35% | 6.35% | 4.98% | 6.25% | 6.65% | 12.21% |
Return on Invested Capital (ROIC) | 12.20% | 12.33% | 8.39% | 11.67% | 16.14% | 30.73% |
Return on Capital Employed (ROCE) | 11.10% | 11.10% | 9.00% | 10.50% | 11.00% | 19.30% |
Earnings Yield | 2.77% | 3.68% | 2.66% | 2.54% | 3.74% | 2.25% |
FCF Yield | 1.46% | 1.93% | 2.02% | 2.00% | 0.69% | 0.52% |
Dividend Yield | 0.89% | 1.18% | 1.14% | 1.10% | - | - |
Payout Ratio | 28.87% | 28.87% | 47.17% | - | - | - |
Buyback Yield / Dilution | -0.13% | -0.13% | -0.01% | -0.03% | -0.09% | -3.96% |
Total Shareholder Return | 0.76% | 1.05% | 1.13% | 1.07% | -0.09% | -3.96% |